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INTRODUCTION 
Mitral valve is much more complex than the semilunar valve.  The mitral 
valve consists of six major anatomic components: The posterior left atrial wall, 
annulus, leaflet, chordae tendinae, papillary muscles and left ventricular free 
wall.  The circumference of the normal mitral valve ranges from 8 to 10.5 cm 
(Mean 9.4).   
 Mitral valve consists of two leaflets.  The anterior leaflet has a much 
longer base to margin of closure width (2.3cm) than posterior leaflet (1.2cm), but 
the circumference (6cm) of the posterior leaflet (annular attachment) is about 
twice that of the anterior leaflet (3cm). 
 The anterior leaflet is large and semicircular, and it partially separates the 
ventricular inflow and outflow tracts. However, unlike its right-sided counterpart, 
it also forms part of the outflow tract. The posterior mitral leaflet is rectangular 
and is usually divided into three scallops1, 2. The middle scallop is the largest of 
the three in more than 90 percent of normal hearts. Occasionally, however, either 
the anterolateral or the posteromedial scallop is larger, and rarely there are 
accessory scallops. 
  Posterior mitral leaflet prolapse usually involves the middle scallop and 
may be associated with chordal rupture. Both mitral leaflets are normally similar 
in area. The anterior leaflet is twice the height of the posterior leaflet but has half 
its annular length3. With advanced age, the mitral leaflets thicken somewhat, 
particularly along their closing edges4.  
 
 The commissures are cleftlike splits in the leaflet tissue that represent the 
sites of separation of the leaflets. Beneath the two mitral commissures lie the 
anterolateral and posteromedial papillary muscles, which arise from the left 
ventricular free wall. Commissural chords arise from each papillary muscle and 
extend in a fan-like array to insert into the free edge of both leaflets adjacent to 
the commissures (major commissures) 5 or into two adjacent scallops of the 
posterior leaflet (minor commissures). The attachments of commissural chords 
precisely demarcate the commissure.  
The anterolateral papillary muscle is commonly single and usually has a 
dual blood supply from the left coronary circulation6.  In contrast, the 
posteromedial papillary muscle usually has multiple heads and is most commonly 
supplied only by the right coronary artery. Small left atrial branches supply the 
most basal aspects of the mitral leaflets. Papillary muscle contraction pulls the 
two leaflets toward one another and thereby promotes valve closure. 
 The line of closure for either mitral leaflet is not its free edge but an ill-
defined junction between a thin, clear zone and a thicker, rough zone. The major 
chordae supporting a leaflet insert into its free edge and rough zone. The chordae 
tendineae anchor and support the leaflets and, by doing so, prevent leaflet 
prolapse during ventricular systole.  Two particularly prominent rough zone 
chords, referred to as strut chordae, insert along each half of the ventricular 
surface of the anterior mitral leaflet and tend to calcify with age.  Unlike the 
tricuspid valve, the normal mitral leaflets have no chordal insertions into the 
ventricular septum. 
Mitral stenosis (MS) an obstruction to blood flow between the left atrium 
and left ventricle is caused by abnormal mitral valve function.  In virtually all adult 
patients, the cause of MS is previous rheumatic carditis. 
Rheumatic fever results in four forms of fusion of mitral valve apparatus 
leading to stenosis: 1.Commissural 2.Cuspal 3.Chordal, and 4.combined. 
The typical M-mode and 2D echocardiographic features of rheumatic mitral 
stenosis include the following. 
1. Thickened and calcified mitral leaflet and subvalvular apparatus 
2. Decreased E-F slope  
3. “Hockey –Stick” appearance of anterior mitral leaflet in diastole 
4. immobility of the posterior mitral leaflet 
5. Fish mouth orifice in the short axis view  
6. Increased LA size. 
The mitral valve area can be measured by  
1. Planimetry  
2. Pressure-half time  
3. Continuity equation 
4. PISA (Proximal isovelocity surface area).  
The following categorize the severity of mitral stenosis according to mitral valve 
area. 
Normal,    4 to 6 cm2 
Mild,       1.6 to 2.0 cm2 
Moderate, 1.1 to 1.5 cm2 
Severe,      1.0cm2 or smaller 
Mitral stenosis is considered severe when the  
1. Resting mean pressure gradient is ≥10 mmHg 
2. Mitral valve area is ≤ 1.0cm2 
3. Pressure half time is ≥ 220 milliseconds. 
Management of mitral stenosis includes 1. Medical 2. Surgical, and 3. 
Interventional therapies.  
The interventional therapy is usually performed in patients with severe MS 
and occasionally in patients with moderate MS.In patients undergoing balloon 
mitral valvuloplasty (BMV), an echocardiographic score based on valve thickness, 
calcification, mobility and subvalvular thickening can be used to predict the 
outcome of the procedure.  The patients with an echocardiographic score of 8 or 
less have a more favorable result from BMV than those with a higher score, but a 
score higher than 8 does not preclude the option of valvuloplasty. Commissural 
calcification or fusion is another important determination of poor outcome after 
percutaneous valvuloplasty or valvotomy. 
 
                 Although conventional 2D echocardiography is still the gold 
standard for evaluating mitral stenosis during BMV, measurement of mitral 
valve area relics largely on the experiences of the observers, which at times 
may be inaccurate and not always reproducible, With the recent 
introduction of a novel, high speed, volumetric scanner system, realtime, 
3D echocardiography (RT3DE) could be used to display the mitral valve 
and its relation to neighboring structures in real time.  It has great potential 
in assessing morphological characteristics of the mitral valve apparatus and 
in determining the valve orifice are, combined with quantative analysis 
software during BMV. 
 
 
 
 
 
 
 
                                
REVIEW OF LITERATURE 
The Inoue balloon catheter was the first catheter system developed for 
nonsurgical mitral valvuloplasty in patients with mitral stenosis7.  As a result of 
extensive clinical trials, mitral valvuloplasty using the catheter, referred to as 
percutaneous transvenous mitral commissurotomy (PTMC) has become an 
effective and safe alternative to surgical treatments of patients with rheumatic 
mitral stenosis. 
HISTORIC PERSPECTIVE 
Beginning in the early 1960’s several balloon catheter intervention 
techniques emerged as alternatives to surgical treatment of cardiovascular 
diseases.  These included extraction of arterial emboli and thrombi, dilation of 
arteriosclerotic stenosis of peripheral vessels, and atrial septostomy for cyanotic 
congenital heart diseases.  Inspired by these innovations, Inoue began to design 
and develop a new catheter system in 1976.  A prototype double-lumen coaxial 
balloon catheter was perfected in July 1980 and was used to create an atrial septal 
defect in children with transposition of the great arteries, tricuspid atresia, and 
other types of cyanotic heart disease8.  It also was used to treat membranous 
obstruction of the hepatic portion of the inferior vena cava and stenotic lesions in 
ileofemoral arteries9. 
The ability of the balloon to separate fused commissures of the mitral valve 
was evaluated under direct vision as an auxiliary means of open mitral 
commissurotomy in 197910.   
The fused commissures were separated precisely along their natural lines 
without injury to the leaflets, tearing of the chordae tendineae, or creation of 
significant mitral regurgitation.  The technique of inserting the balloon catheter 
across the mitral orifice by transseptal catheterization via the femoral vein was 
concurrently studied in canine experiments11. On June 3,1982, the first clinical 
application of the prototype balloon catheter was successfully achieved in a 33 
year-old man with severe rheumatic mitral stenosis12. 
The prototype balloon catheter used in the early stage of clinical trials had a 
large-profile balloon that required a cut-down for insertion into the saphenous 
vein.  Subsequent modifications in catheter design enabled percutaneous 
introduction of the catheter through the patient’s femoral vein, and the procedure 
thus was named percutaneous transvenous mitral commissurotomy13.  The groin 
entry site of the catheter in the past was dilated with a 16 Fr. dilator while the 
atrial septum was dilated with a 14 Fr. 70cm dilator.  Further refinements reduced 
the catheter shaft size from 14 to 12 Fr. and combined the two dilators into a 
single 14 Fr.dilator that allowed simultaneous dilatation of the atrial septum and 
the femoral vein. 
INOUE BALLOON CATHETER SYSTEM 
The instruments used in PTMC consist of a balloon catheter and its 
accessories.  Before execution of the PTMC procedure, the operator and assistants 
should familiarize themselves thoroughly with the structure and function of the 
Inoue balloon catheter system. 
 
INOUE BALLOON CATHETER 
The balloon catheter has a 12Fr. Polyvinyl chloride tube shaft with a 
coaxial double-lumen. The inner lumen of the catheter permits pressure 
measurements, blood sampling, and insertion of a metal tube, guidewire, or stylet. 
The outer lumen connects proximally with a two-way stopcock used to connect the 
catheter to an inflation/deflation syringe and a vent and distally with a balloon 
mounted at the end of the shaft.  The balloon is made of double layers of latex 
tubing. The balloon can be used transformed to various shapes from its natural 
form to serve different functions.  The balloon section is stiffened and slenderized 
when the rubber balloon is stretched by inserting a metal tube.  The slenderized 
balloon allows a smooth entry of the balloon catheter into the femoral vein without 
the use of an introducer set. It also permits an easy passage of the catheter across 
the atrial septum.  The balloon changes its shape in three stages, depending on the 
extent of inflation.  Initially only the distal half inflates followed by the proximal 
half with a constriction remaining in the middle.  The constriction finally 
disappears when the balloon attains full inflation. 
 
AUXILIARY INSTRUMENTS 
An 80-cm 18-guage metal tube; the tube is inserted to lock with the inner 
lumen tube, thereby stiffening the catheter tip.  The catheter tip is slenderized 
further (diameter of 4.5 mm and length of 60 mm) by pushing the metal hub of the 
inner tube to a locked position.  
A 70-cm, 14 Fr. Polyethylene dilator; It is used to dilate the atrial septum 
and the femoral vein at the same time.  
A 180-cm, 0.025-inch stainless steel guide wire with coiled floppy tip; 
the guide wire is inserted through the transseptal catheter across the atrial septum 
to guide the balloon catheter to the left atrium.  
An 80-cm, 0.0038-inch high-torque J-tipped spring wire stylet; the stylet 
has a preformed J-shaped tip with a waist length of approximately 4.5 cm. After 
the balloon catheter is placed in the left atrium, the stylet is inserted, which 
provides excellent steerability and facilitates direction of the balloon tip toward 
the mitral orifice.  Axial movement of the catheter is made by 1.1 torque control of 
the stylet.  When the stylet is withdrawn from the catheter, the catheter tip 
advances forward, and vice versa.   
A 30-ml plastic syringe and connecting tube; the extent of balloon 
inflation is controlled by adjusting the volume of diluted contrast material in the 
syringe, which is injected manually through a two-way stopcock.  
A caliper; the caliper is used to measure the diameter of inflated balloons.  
 
 
 
 
 PTMC
• The instruments used in PTMC consist of a
– Balloon catheter and its accessories
– Instruments used for transeptal puncture
Before execution of the PTMC procedure, the operator and assistants 
should have thoroughly familiarized themselves with the structures and 
functions of the Inoue balloon catheter system.
 
Picture 1 Instruments of PTMC 
 
 
 
 
 
 
 
PROCEDURE 
Before BMV, anticoagulant therapy heparin 2500U always was given.  The 
BMV was performed on fasting patients after premedication (10mg oral diazepam 
and 0.5 mg subcutaneous atropine).  Appropriate intravenous fluid replacement 
was given routinely throughout the procedure the antegrade approach was used in 
all cases. A transeptal catheterization   was performed via the right femoral vein, 
using a standard Brokenbrough needle, a Mullins sheath (8 Fr.USCI), and a dilator 
(Cook).  The atrial puncture was carried out using anteroposterior and 30-degree 
right anterior oblique views, under continuous pressure monitoring. The 
interaterial septum was dilated using a peripheral angioplasty balloon 8 mm, in 
diameter. Finally, the balloon was positioned across the mitral valve, their position 
being confirmed by fluoroscopic detection of the mitral valve indentation during 
the first inflation.  
Balloon size is chosen in accordance with the patients height (height in cm 
divided by 10 and added 10).  The balloon is inflated sequentially.  First the distal 
portion is inflated with 1 or 2ml of a diluted contrast medium and acts as the 
floating balloon catheter in crossing the mitral valve. Second, the distal part is 
further inflated and then the balloon is pulled back into the mitral orifice; inflation 
then occurs at the level of the proximal part and finally in the central portion, with 
the disappearance of the central waist at full inflation.  A stepwise dilation 
technique under echocardiographic guidance is used14.  The first inflation is 
performed 4 mm below the maximal balloon size is increased in steps of 2mm 
each.  
 The balloon then is deflated and withdrawn into the left atrium. If mitral 
regurgitation as assessed by color Doppler echocardiography, has not increased by 
over one grade and valve area, is less than 1cm2 /m2 of body surface area, the 
balloon is readvanced across the valve and PTMC is repeated with a balloon 
diameter increased by 2 mm larger. 
  The following criteria are used for ending the procedure: (1) mitral valve 
area greater than 1cm2 /m2 of body surface area (2) complete opening of at least 
one commissure or (3) appearance of mitral regurgitation or increment of 
regurgitation greater than one grade. After the procedure, the catheters were 
withdrawn immediately and manual compression was started. Heparin was 
continued subcutaneously for 24 hours and patients usually were discharged 2 to 3 
days later. 
MECHANISM       
Mitral balloon valvotomy relieves mitral stenosis by splitting fused 
commissures, which is similar to surgical commisssurotomy.  This mechanism has 
been demonstrated by pathologic specimens or intraoperative balloon dilation. 
Two dimensional echocardiography also has demonstrated cleavage of the mitral 
valve along the commissures after BMV. Such undesirable outcomes as leaflet 
tears, ruptured chordae, ruptured papillary muscles, and myocardial perforation 
could occur.  The use of balloons too large for the size of the mitral annulus 
usually results in leaflet tears or separation of the mitral leaflet from the annulus.  
     
 
COMPLICATION 
Larger series are available and enable better assessment of the risk of 
complication in the BMV technique. Procedural mortality ranges from 0 to 3 
percent in most series. The main cause of the death is left ventricular perforation 
or the poor general condition of the patient.   
Mortality is higher in multicenter studies than in those from single large-
volume centers, which reflects the importance of training. 
 The incidence of hemopericardium varies from 0.5 to 7 percent. 
Pericardial hemorrhage may be elated to transeptal catheterization or to apex 
perforation by the guide wires or balloon itself when exaggerated movement 
occurs. Here again, studies describing the practice of single groups report a lower 
incidence of hemopericardium than in multicenter studies. Several technical 
modifications have been proposed to lessen the risk of apex perforation: careful 
preshaping of the guide wires or their placement in the aorta; use of a com-
bination trefoil and conventional balloon15. This seems to be more stable than two 
conventional balloons; 
 When it does occur, pericardiocentesis in the catheterization laboratory 
usually allows stabilization of the patient's condition and secondary transfer for 
cardiac surgery. Ramsdale and Schofield reported one case of endomyocardial 
trauma, without hemopericardium, caused by the rigid tips of the balloons. It re-
sulted in transient hypotension, ST segment depression, and low cardiac output. 
 
Embolism is encountered in 0.5 to 5 per cent of cases. It is very seldom 
the cause of permanent incapacitation and even more seldom the cause of death. 
Embolism may be cerebral or coronary in location, occurring mainly in the right 
coronary artery. It can be due to gas when it occurs immediately after balloon 
rupture, to fibrinothrombotic material, or, very seldom, to calcium. Although the 
incidence of embolism is low, its potential consequences are severe, and all 
possible precautions must be taken to prevent it. These include:  
Full anticoagulation for at least 2 months before PTMC in cases of atrial 
fibrillation or if there is history of thromboembolic event. Careful detection of 
thrombi by using transesophageal echocardiography immediately before the 
procedure. This better images the left atrium, and especially the left atrial 
appendage, than does the transthoracic approach. When doubt persists, patients 
must exclude from PMC. Heparinization during the procedure, because recent 
transesophageal studies performed during PTMC have shown that transeptal 
catheter-related thrombi may occur during PTMC.   
In most cases, the degree of mitral regurgitation remains stable or, more 
often, slightly increases after PTMC. Cases of mild increase in the degree of 
regurgitation are best shown by echocardiography, especially when using the 
transesophageal approach with color-flow Doppler. The small jets of regur-
gitation usually are localized in the open commissural area. They may be related 
to small tears in the leaflet, localized rupture of chordae, or incomplete closure of 
a rigid leaflet and shortened chordae tendineae after splitting of the commissure. 
 
In the series of Essop et al. a prolapse of the anterior leaflet was 
responsible for a mild increase in mitral regurgitation in 23 per cent of patients 
with pliable valves. Finally, the role of transient traumatic or ischemic papillary 
muscle dysfunction has been posited but remains unproved. Conversely, in a few 
cases the degree of mitral regurgitation may clearly decrease, probably because of 
increased mobility of the leaflets.  
Severe mitral regurgitation is rare, its frequency ranging from 2 to 19 per 
cent16. Surgical findings have shown that it is related to noncommissural tearing of 
the posterior or anterior leaflet. In these cases, one or both commissures are too 
tightly fused to be split. It also may be due to excessive commissural splitting, or 
in very rare cases to rupture of a papillary muscle. Severe mitral regurgitation can 
be observed in noncalcified valves, especially when unexpectedly abundant 
myxoid connective tissue is present at the site of rupture. 
 In our experience, anatomic findings at surgery showed that severe mitral 
regurgitation occurred in patients with unfavorable anatomy, because all had 
extensive subvalvular disease and half had valve calcification. Severe mitral 
regurgitation may be well tolerated, but in our experience more often it is not, and 
surgery on a scheduled basis is necessary. This is in agreement with previous 
surgical series, which have shown an unfavorable outcome in patients with mitral 
regurgitation occurring after commissurotomy. In most cases, valve replacement is 
necessary because of the severity of the underlying valve disease. Conservative 
surgery, combining suture of the tear and commissurotomy, has been performed 
successfully in cases with less severe valve deformity. In groups with good ex-
perience in mitral valve reconstruction, the need for valve replacement is more 
closely related to the extent of valve disease than to the tear itself. 
 The frequency of atrial septal defect reported17, after PTMC varies from 
10 to 90 per cent according to the technique used for its detection. Such shunts are 
detected in 10 to 30 per cent by the oximetry method, which lacks sensitivity when 
compared to the indicator dilution method, which gives an incidence of 62 per 
cent, and to color-flow Doppler imaging, in which shunts are shown in 38 to 90 
per cent of cases. 
 The transesophageal approach, which allows excellent visualization of the 
whole septum, appears to be the most sensitive method. These shunts usually are 
small and restrictive, with high-velocity flow. As regards oximetry, this QP / QS 
ratio is over 1.5 in only 5 per cent and very seldom is over 2. Right-to-left shunts 
can occur on rare occasions in patients with elevated right heart pressures and 
pulmonary hypertension. 
 Recent studies have shown that shunting after PTMC is related to clinical 
variables (age, low cardiac output; valvular calcification, high echocardiographic 
score, previous surgical commissurotomy), to the valve area obtained after PTMC, 
and to technical factors (site of transseptal puncture, duration of the procedure, 
and type and size of balloon used). As regards the technical factors, Fields et al. 
have shown that, when using a two-balloon technique, the size of the atrial septal 
defect is minimized by a single transseptal puncture and the sequential withdrawal 
of the completely deflated balloons. Atrial septal defect also can be created by the 
inflation of the most proximal part of the balloon while inadvertently positioned 
across the atrial septum, which may occur when a long balloon is used or when 
excessive traction is exerted to withdraw the balloon at full inflation. 
 The incidence of transient, complete heart block is 1.5 per cent, and it 
seldom requires a permanent pacemaker.  After the transvenous approach, 
vascular complications are the exception. Urgent surgery (within 24 hours after 
PMC) is seldom needed for complication resulting from PMC. It may be required, 
however, for massive hemopericardium resulting from left ventricular perforation 
unresponsive to pericardiocentesis, or less frequently, for severe mitral regurgi-
tation leading to hemodynamic collapse or refractory pulmonary edema.  
Overall, when performed by experienced teams on properly selected 
patients, PMC is of relatively low risk. Furthermore, the procedure is not 
accompanied by the usual perioperative events (i.e., morbidity, infectious disease, 
chest wall damage, or pericarditis), and by the later thromboembolic, infectious, 
and degenerative complications that may occur when valve replacement has been 
performed. 
 
 
 
 
 
 
TRANS THORACIC ECHOCARDIOGRAM 
All patients with symptomatic mitral stenosis are potential candidates for 
BMV.  The two dimensional and Doppler echocardiographic examinations is the 
most important test to identify which patients should have the procedure.  An 
echocardiographic score has been developed in which valve rigidity; valve 
thickening, valve calcification, and subvalvular fibrosis are graded 0 (least) to 4 
(most).  The sum of the four components then gives an echocardiographic score.  
 If the cumulative score is 8 or less, the patients are generally a good 
candidate for BMV.  If the score is greater than 9 but less than 12, the results of 
BMV are variable, although patients can still be considered candidates for the 
procedure. If the echocardiographic score is 12 or more, BMV should only be 
undertaken if mitral valve replacement is contraindicated.  The results of BMV in 
patients with severe valve thickening, rigidity, calcification, and severe 
subvalvular fibrosis are not satisfactory. Evidence of left thrombus, a recent 
embolic event, severe mitral valve calcification, or severe subvalvular thickening 
and fibrosis are contraindications for BMV. 
  The presence of left ventricular thrombus in an area of an old myocardial 
infarction (if the patient has associated coronary artery disease) is also a 
contraindication because the thrombus can be dislodged by passage of the 
guidewires or the dilating balloons into the left ventricle. Since atrial fibrillation 
increases the likelihood of left atrial thrombus, patients with atrial fibrillation 
should receive anticoagulation therapy for 2 to 3 months before BMV and 
echocardiography should show no evidence of left atrial thrombus before the 
procedure is undertaken. 
 A transesophageal echocardiogram should be performed if there is doubt as 
to the presence or absence of left atrial thrombus.  If left atrial thrombus is 
suspected, BMV should not be performed. Instead, 2 to 3 months of additional 
anticoagulation therapy with warfarin is indicated, with repeat echocardiographic 
examination thereafter.  
Grading of characteristics of mitral valve morphology from 
echocardiographic examination  
Leaflet mobility 
Grade 1. Highly mobile Valve with restriction of only the leaflet tips  
Grade 2. Mid-portion and base of leaflets have reduced mobility 
Grade 3. Valve leaflets move forward in diastole mainly at the base 
Grade 4. No or minimal forward movement of the leaflets in diastole 
Valvular thickening 
Grade 1. Leaflets near normal (4-5mm) 
Grade 2. Mid-leaflet thickening, marked thickening of the margins(5-8mm) 
Grade 3. Thickening extends through the entire leaflets (5-8mm) 
Grade 4. Marked thickening of all leaflet tissue (>8-10mm) 
Subvalvular thickening 
Grade 1. Minimal thickening of chordal structures just below the valve 
Grade 2. Thickening of chordae extending up to one third of chordal length 
Grade 3. Thickening extended to the distal third of the chordae 
Grade 4. Extensive thickening and shortening of all chordae extending 
down to   the papillary muscle 
Valvular calcification 
Grade 1. A Single area of increased echo brightness  
Grade 2. Scattered areas of brightness confined to leaflet margins  
Grade 3. Brightness extending into the mid-portion of leaflets 
Grade 4. Extensive brightness through most of the leaflet tissue.                                            
    
   
 
THREE DIMENSIONAL ECHOCARDIOGRAM 
Whereas, conventional two dimensional (2D) Echocardiography is crucial to our 
understanding of the complex anatomy and three dimensional (3D) spatial relationships 
of cardiac structures, it requires the mental integration of a limited number of 2D imaging 
planes. This mental 3D reconstruction is inherently variable according to observer 
experience and expertise, and can only be described to other clinicians (such as surgeons) 
rather than  
displayed reproducibly.  The display of cardiac anatomy in three dimensions from any 
perspective would have clear advantages over conventional 2D imaging and provide an 
insight into the functional and anatomic properties of cardiac structures.  
 
Recent advances in ultrasound and computer technology have been combined 
such that dynamic 3D echocardiographic imaging is now a practical reality. Three 
dimensional echocardiography (3DE) has been shown to be more accurate than 2DE in 
the quantification of cardiac volumes18. These studies used either manually contoured, 
static “wire frame” reconstructions or dynamic “volumetric” automated reconstruction 
technology that is now commercially available—we concentrate on the latter 
methodology in this review. 
  
The benefits of 3DE are particularly well suited to the study of the mitral valve 
given its complex morphology and the importance of delineating its anatomy precisely in 
various pathological states. This was shown by Levine et al who used wire frame 
reconstruction of the mitral valve to define the 3D morphology of the mitral annulus and 
its relationship to mitral leaflet position, thereby clarifying the echocardiographic 
definition of mitral valve prolapse19. The assessment of patients with mitral valve disease 
is one of the most promising clinical applications of this technology. 
 
DATASET ACQUISITION, PROCESSING AND RECONSTRUCTION 
A 3D dataset is composed of anatomical information from multiple 2D cross 
sectional 
images. For reconstruction of the mitral valve in adult patients, transthoracic 
echocardiography (TTE) is the routine approach for 2D image acquisition as it offers a 
relatively stable site for the imaging probe and superior resolution of the mitral valve 
apparatus. Images from transthoracic echocardiography (TTE) are interfaced with a 3D 
computer system which incorporates the steering logic for acquisition of a rotational 
dataset and software for 3D reconstruction and display.  
 
  Optimal temporal and spatial registration is achieved by ECG and respiratory 
gating. Offline processing involves the conversion from polar to cubic Cartesian co-
ordinates and interpolation of missing information between 2D slices. From the resultant 
dataset, novel 2D cut planes in any orientation can be selected (any plane echo) and 
multiple parallel cross sectional 2D slices can be generated in any desired plane (Para 
plane echo). A volume rendered 3D image of the mitral valve can be reconstructed from 
any perspective. Threshold limits are used to separate cardiac structures from blood pool 
and background. 
Brightness and shading provide perception of depth. With the added dimension of time 
we 
are able to study in detail the motion of the valve during the cardiac cycle. 
 
IMAGE DISPLAY AND ANALYSIS 
  The digitized data were reformatted and interpolated into a cubic data set by 
filling in the gaps between pixels to create individual volume elements or voxels. This 
cubic data set could then be rotated in any direction, allowing unlimited cut planes 
irrespective of the original ultrasonographic window. Once a cut plane was chosen, a 
volume-rendered three-dimensional image was produced by a combination of distance, 
gradient and texture shading. For our study a short-axis view of the left ventricle at the 
level of the papillary muscle was used to view the mitral valve (as if looking up from the 
left ventricle into the valve). 
 The mitral valve leaflets, annulus and commissures were identified, inspected and 
compared in both the prevalvuloplasty and postvalvuloplasty studies. The mitral valve 
area was also measured by planimetry in this view. Several tomographic images of the 
valve orifice during diastole were inspected, and the image with the smallest mitral valve 
orifice was used. This was compared with the mitral valve area calculated by the pressure 
half-time method from the continuous-wave Doppler tracing of the mitral inflow velocity 
obtained from the two-dimensional TTE. The degree of mitral regurgitation was 
estimated from the color Doppler signal, also obtained from the two-dimensional TTE. 
 
MITRAL STENOSIS 
In managing patients with mitral valve stenosis, it is essential to obtain 
reliable information about mitral valve structure and area20 although conventional 
2-dimensional echocardiography is still the gold standard for evaluating mitral 
stenosis (MS) in clinical use21. Measurement of the mitral valve area (MVA) 
relies largely on the experiences of the observers, which at times may be 
inaccurate and not always reproducible. With the recent introduction of a novel, 
high-speed, volumetric scanner system, real time, 3-dimensional 
echocardiography (RT3DE) could be used to display the mitral valve and its 
relation to neighboring structures in real-time. It has great potential in assessing 
morphologic characteristics of the mitral valve apparatus and in determining the 
valve orifice area, combined with quantitative analysis software. 
Two-dimensional Echocardiographic examinations were performed with 
patients in the left lateral decubitus position. Electrocardiograms were simulta-
neously recorded in all subjects. A standard Parasternal left ventricular short-axis 
(mitral valve level) view was obtained, adjusting the transducer for optimal mitral 
valve orifice. 
 The MVA was traced point by point along the mitral valve endocardial 
border. Then we selected the apical 4-chamber view, placed the sample volume at 
the mitral valve orifice, recorded the diastolic flow spectrum, and calculated the  
pressure half-time (PHT) (MVA was calculated as 220/PHT).  
New ultrasound equipment (Philips iE.33) was used to permit RT3DE of a 
mitral valve in the parasternal, apical, and sub costal views, We carefully 
adjusted the mitral valve to the center of the screen, opened the "live 3D" 
functional button, acquired pictures in real-time, then randomly rotated the 
picture, carefully observing the mitral valve apparatus and its relation to the 
neighboring structures. During the examination we paid special attention to 
adjusting the parameters to optimally display the 3-dimensional mitral valve 
structure at any given time. Sometimes the scanner angle (60° X 15°) was not 
enough to display the whole mitral valve orifice, 
 Then the "full volume" program was used. With a standard apical 4-
chamber view, we adjusted the mitral valve to the center of the screen, then 
opened the full-volume button, asked the subject to hold his/her breath, then 
acquired the "pyramid," 3-dimensional database (80° X 90°) from sequential 4 
cardiac cycles. All images were stored on disks for off-line analysis. 
 
 
 
Picture 2: Full volume 3D acquisition image in 4 beats (80X900) 
 Data are presented as mean ± SD for descriptive statistics. We chose the 
average values for 3-time measurements. The linear regression analysis and 
paired Student's t test were used. To assess the effect of intra- and interobserver 
variabilities on the 3-dimensional measurements of the MVA, 10 randomly 
selected patients in the MS group were analyzed twice by one observer and at 
different times by two independent observers. A  p value <0.05 was considered 
statistically significant22. 
 The 3-dimensional structures of the mitral valve in 64 subjects were 
clearly and vividly demonstrated. We were able to observe the morphologic 
appearance of the mitral valve apparatus and its relation to neighboring structures 
from a different azimuth and angle using a randomly rotated mode in the live 3-
dimensional program. 
 The normal mitral valve orifice in the birds-eye view from the left 
ventricular side demonstrated the intact mitral valve apparatus with tenuous valve 
leaflets and free mobility. However, mitral valve orifices in patients with MS 
were obviously smaller than those in normal controls; parts of the contracted 
mitral valve orifice in patients with MS were calcified with fused and thickened 
leaflets.  
With the recent introduction and successful application of percutaneous 
balloon valvuloplasty for nonsurgical relief of symptomatic MS23, it is crucial to 
obtain accurate measurement of the MVA. Two-dimensional echocardiography 
has been the standard method to determine MVA in routine clinical practice. 
Because two dimensional echocardiography is limited by the quality of the 
acoustic window and the experience of the operator; the accuracy and 
reproducibility of valve area measurement is suboptimal. 
 In clinical situations, the symptoms of patients with MS and the pressure 
measurements obtained at cardiac catheterization were often not in agreement 
with the area measurements from 2-dimensional echocardiography. The main 
reason for this discrepancy is the difficulty in acquiring the plane of the smallest 
MVA on routine examination. Furthermore, traditional 2-dimensional 
echocardiography could only image the MVA in a 2-dimensional plane; however, 
the asymmetry and complex structure of the mitral valve make it difficult to 
determine the MVA, which is not located in the same plane. 
 Compared with the 2-dimensional technique, both static and dynamic 3-
dimensional echocardiography provides more information about cardiac anatomic 
structures without any arbitrary geometric assumptions23. However, this complex 
acquisition and off-line data processing proved cumbersome and impractical for 
routine clinical use. With the new development of RT3DE, it became possible to 
rapidly evaluate the mitral valve structure and area. RT3DE with a high-speed 
volumetric ultrasound system developed at Duke University is based on the use of 
a 16:1 parallel processing schema from a 2- to 4-MHz matrix, phased-array 
scanner. The 16.times improvement in the data acquisition rate allowed one to 
interrogate an entire 3-dimensional pyramidal volume in real-time.  
 Images in the region of interest may be viewed in real-time or in a 7 
cardiac-cycle-captured volume without respiratory and electrocardiographic 
control.  This novel, real-time, 3 dimensional echocardiography systems is now 
available for clinical use.  
 
Three dimensional echocardiography has a role in both the quantitative and 
qualitative assessment of mitral stenosis. Three dimensional echocardiography 
overcomes the limitations of image plane positioning inherent in conventional 2DE and 
offers a more precise 
approach to measurement of mitral valve area. Para plane 3DE allows the 2D short axis 
slice in the optimum plane of the orifice to be selected from the 3D dataset and the 
smallest Complete orifice can be directly measured by planimetry. Anterior leaflet 
calcification often produces acoustic shadows which obscure the mitral orifice in the 2D 
transthoracic short axis plane. Chen et al assessed 15 patients with mitral stenosis and 
showed this 
technique to correlate more closely with the Doppler pressure half time derived area 
compared with 2D echo planimetry.  
  
The shape of the mitral valve leaflets proximal to the orifice has an impact on the 
flow dynamics across a valve. 3DE with stereolithographic modeling has been used to 
demonstrate that flat shaped valves cause a higher pressure gradient for the same 
anatomic area and flow rate compared with “funnel” shaped valves. Thus, 3DE provides 
insights into mitral leaflet geometry which could refine our assessment of mitral stenosis. 
 
  3DE also appears to be of value in the assessment of patients undergoing balloon 
mitral valvotomy (BMV) where the dominant mechanism is splitting of fused mitral 
commissures. Studies using 2DE have shown that commissural morphology is a powerful 
predictor of outcome after BMV and at our institution this forms the cornerstone of 
assessment of patients with mitral stenosis referred for valvotomy. Viewed from the left 
atrium, 3D reconstruction of mitral stenosis displays the restricted orifice, thickened 
leaflet margins and prominent left atrial appendage. In our experience, the volume 
rendered 3D display provides improved visualization of mitral commissural fusion, 
particularly when the leaflets are viewed from the perspective of looking upwards from 
the left ventricle. Following balloon valvotomy, 3DE also defines clearly the extent and 
site of commissural splitting which may be symmetrical or eccentric.  
 
LIMITATIONS OF THREE DIMENSIONAL ECHOCARDIOGRAPHY 
The standard of the 3D reconstructed display depends critically on the quality of 
the original 2D cross sectional images. Until recently, in adult patients, this necessitated 
TEE. However, the development of harmonic imaging has made it feasible to reconstruct 
from a transthoracic rotational dataset. Minor movements of either patient or operator 
will distort the images and result in dropout which may be misinterpreted.  
 
Atrial fibrillation or a variable respiratory pattern prolongs the acquisition time 
and impairs the dataset resulting in artifact. Operator dependent changes in threshold 
settings, which define the tissue–blood interface on the 3D rendered display, can affect 
the apparent mitral orifice.Therefore; measurements on reconstructed images should be 
made with caution 
  
Spontaneous echo contrast in mitral stenosis hinders reconstruction of the valve 
from the left atrial perspective; this can be minimized by reducing the probe frequency. 
Highly mobile structures such as a ball valve thrombus, vegetations, and ruptured chords 
are not easily seen. In our opinion, 3DE has not improved visualization of the mitral 
subvalvar apparatus and areas of calcification are not apparent in the volume rendered 
display. At present this technology provides information which complements that gained 
from a comprehensive 2D and Doppler echocardiographic study. 
 
 
AIM OF THE STUDY 
Three-dimensional echocardiography is a recently developed, evolving 
imaging technique that allows visualization of intra cardiac structures from any 
perspective. 
This study aims at utilizing real time three-dimensional transthoracic 
echocardiography (RT3DE) technique for comprehensive assessment of  
- cardiac anatomy 
- cardiac pathophysiology 
- pathomorphology 
in patients with rheumatic mitral stenosis who underwent Balloon 
mitral valvotomy (BMV). 
 
 
 
 
                                         
                                                                      
 
                                               
STUDY DESIGN 
This study was performed in the Department of Cardiology, Government 
General Hospital, Chennai, during the year 2004 – 2007. 
STUDY INDICATION 
Study indication was for the comprehensive assessment of cardiac anatomy 
and pathomorphology of rheumatic mitral stenosis who undergoes balloon mitral 
valvotomy. 
STUDY GROUP SELECTION 
Study groups are those who were referred and admitted for the management 
of rheumatic mitral stenosis. 
Candidates for balloon mitral valvotomy were carefully evaluated by 
history taking, physical examination and laboratory tests, including 
electrocardiography chest radiographs, and echocardiography.  Color Doppler two-
dimensional echocardiography is essential to evaluate mitral valve morphologies 
and assess the degree of mitral regurgitation.  Transesophageal echocardiography 
is performed to verify the presence or absence of left atrial thrombi. 
EXCLUSION CRITERIA 
1. Mitral regurgitation – moderate and more 
2. Moderate and more calcification of mitral valves 
3. Fresh left atrial thrombus  
4. thrombus on atrial septum 
5. Mobile thrombus 
STUDY POPULATION 
The study group consisted of 35 rheumatic mitral stenosis (severe) patients 
consisting of 21 males and 14 females, (mean age = 32.3+ 9.2 years, range = 22 to 
45 years); The purpose and methodology were explained to the study subject in 
detail, and informed consent was obtained. 
All the patients were subjected to clinical examination, ECG, X-ray chest, 
TTE and 3D Echocardiogram prior and post to balloon mitral valvotomy.  TEE 
was done in selected individual to rule out LA clot. (n=5) 
CLNICAL EVALUATION 
The patients were either in class II (21out of 35, 60%) or in class III (14 out 
of 35, 40%) of the New York Heart association functional classification. All 
patients underwent thorough clinical evaluation before the study. One patient 
underwent prior BMV 9 years back. None of the study patients were on 
anticoagulant or antithrombotic drug therapy, and all were on mild oral diurectic, 
oral penicillin’s and potassium chloride syrups. Complete haemogram and basic 
blood biochemical analysis were normal in all the subjects. All the baseline 
clinical characteristics and investigate parameters of the study population are 
listed in the Table (1) & (2)  
Table-1: Baseline and 2D echocardiographic characters of patients 
Pressure data of BMV (mmHg) 
 
 
 
 
 
Table-2: Baseline haemodynamic characters of patients 
METHODOLOGY 
Age 
NYHA   
Left atrial size(mm) 
MVO planimetry(cm2) 
MVO PHT (msec) 
Wilkins score  
Pulmonary artery 
pressure(mmHg) 
Mitral   
22 – 45 years 
II – III 
4.5 ± 3.2 
0.7 ± 0.17 
325 ± 60 
3 ± 2 
59.8 ± 18.6 / 39.0 ± 13.5  
 
PG 25 ±8.18 MG 16.1 ±5.36 
Aorta 
LV 
PA 
RV 
LA 
106 / 74 / 50 
118 / 10 
90 / 61 / 42 
90 /14 
42 / 27 / 19 
(a) (mean) (v) 
ECHOCARDIOGRAPHY  STUDY 
                   All the subjects in the study population underwent both transthoracic 
2D and 3D echocardiographic examination prior and post to Balloon Mitral 
valvotomy, which were recorded on ½ inch VHS vide tape for further off-line 
analysis. 
TRANSTHORACIC ECHOCARDIOGRAPHY 
Transthoracic M-mode, Two-dimensional, colour flow Doppler, pulsed and 
continuous wave Doppler and RT3DE (real time 3D echocardiogram) were 
performed in all the subjects, with Philips i.E. 33 ultrasound machine using X3-1 
phased array transducer. 
With the subject in left lateral decubitus position, continuous heart rate and 
single lead ECG on-line monitoring was done, and a complete TTE and RT3DE 
examination was performed following conventional criteria in multiple views. M-
mode, 2D, Doppler and colour flow imaging of the mitral valve and related 
parameters were analyzed. Evaluation of LA size was done by M- mode and two-
dimensional echocardiography.  According to the American society of 
echocardiography criteria, LA dimension in M-mode by TTE represents the 
distance between the leading edge of the posterior aortic wall echo and leading 
edge of posterior LA wall echo at the level of aortic valve at end-systole. To 
determine the MVA by continuity equation left ventricular outflow tract diameter 
(LVOT), time velocity integrals (TVI) of LVOT and mitral valve measured. This 
equation was not used in aortic and mitral regurgitation.  
 
To determine the MVO area by proximal isovelocity surface area (PISA) 
the following steps were used.1 Zoom the area of the mitral valve from apical 
four chamber view.2. Use color flow imaging of the mitral stenosis jet and 
upward shift of zero baseline for color map (30 to 40 cm/sec aliasing velocity) 3. 
Freeze color flow images in a cine loop and identify an optimal frame to measure 
radius (r) of PIZA in the left atrium .4.Determine the angle (α) between two 
mitral leaflets at the atrial surface and the PIZA formula used.     
 
REAL TIME THREE DIMENSIONAL ECHOCARDIOGRAPHY 
 
In each patient, RT3DE is performed immediately after  2D study using a Philips 
iE 33 ultrasound machine with an X3-1 probe. This probe is unique as it contains 3000 
elements arranged in a rectangular format. Each transducer element is less than the size 
of the human hair. The foot print of the RT3DE probe is almost the same size as that of 
the 2D echocardiography probe. 
 
RT3DE examination is performed from the same windows that are used for 2D 
echocardiography, namely parasternal long axis, parasternal short axis, apical, subcostal 
& suprasternal views .Hence the plane of examination and the views are exactly similar 
to that of 2D echocardiography. 
 
Initially parasternal long axis view of mitral valve is obtained with routine 2D 
echo.. Then one can switch over from 2DE to 3DE  so that 150 X 900 sector of the heart 
structures can be obtained. In case of mitral valve, apart from showing the anterior mitral 
leaflet and posterior mitral leaflet, its ventricular and atrial surface, the subchordal 
structures and papillary muscles can be clearly visualized by the 3D Echocardiography. 
 
                   In the parasternal short axis view, apart from visualizing the fish mouth 
narrowest mitral valve orifice, one can rotate the picture and visualize the extent of 
commissural fusion, presence and extent of commissural splitting (medial, lateral or both 
commissures) can be analyzed post operatively. Any tear in the commissure can be 
visualized,  as extension of splitting, perpendicular or oblique to the commissural line. 
                  
      The RT3DE examination can also be done in the zoom mode to visualize the 
mitral valve or any other region of interest. In the zoom mode a 300 X 600 sector of the 
heart is visualized. This live 3DE can be performed from the standard echocardiography 
window using the standard 2DE windows as starting point. 
          
The entire heart and surrounding structures can be interrogated and we can obtain 
a pyramidal shape datas set. The narrowest portion of pyramid being nearer to the 
transducer and the widest portion is in other end of transducer. The pyramid is about 800 
X 900  in size. The 800  view is obtained as four datas set of 200 each from four cardiac 
cycles and the datas set are merged to get full pyramid. During full volume acquisition 
mode the patient should hold the breath during expiration and the datas are collected from 
four cardiac cycle. 
                            
The full volume data can be analyzed later by cutting it from different direction 
and also by slicing . The entire mitral valve, the orifice and the surface of mitral valve 
can be analyzed from the left atrial side or left ventricular side by post processing. This 
again helps us to obtain an enface view or surgeon’s view of the mitral valve. The mitral 
valve orifice can be measured and the splitting of mitral valve, extension of commissural 
splitting and any tear in the leaflet can also be visualized. 
 
The full volume acquisition can also be performed in the color Doppler mode. 
The size of pyramid is 600 X 900 and it is obtained from seven cardiac cycles with the 
patient holding the breath in expiration. The full volume datas set can be post processed 
and we can clearly visualize the stenotic or regurgitation jets. In case of mitral 
regurgitation, the area of the mitral regurgitation can be directly measured from the 
narrowest portion of the color Doppler jet.                          
 
 
 
 
 
                                            
 
 
 
                      
 
 
 
RESULTS 
Our study group comprised thirty five consecutive patients with rheumatic 
mitral valve stenosis.  There were twenty one male and fourteen female with the 
mean age of 32.3 ± 9.2 yrs (range 22 to 45 years).  Mitral stenosis was the 
predominant valvular lesion in all patients.  In the pre-BMV period, twenty one 
patients had associated mild mitral regurgitation, whereas two patients had 
associated mild aortic regurgitation. None of the patients showed aortic stenosis.  
Regarding the analysis of the tricuspid valve, none of the patients showed 
tricuspid stenosis, but 27 showed tricuspid regurgitation.  Systolic and diastolic 
left ventricular diameters from the parasternal approach were 43±5and 34±8mm. 
All patients were in normal sinus rhythm. 
 Regarding the BMV procedure, the size of the balloon was selected 
according to the body surface index.  The mean body surface was 1.73±0.18, the 
body mass surface index 27.31 ± 5.06 and accordingly the mean INOUE balloon 
used was 28.1 ± 1.20.  No deep anesthesia was used for the BMV.  
Their functional capacities were ranged between class II – class III 
according to New York Heart Association classification (NYHA).  Left atrium 
diameter was 45.1 ± 3.2 mm. Mitral valve orifice areas were 0.7 ± 0.17cm2. Mitral 
valve pressure halftime varied between 325 ± 60ms. Mitral valve peak 
transvalvular gradient 25.0 ± 8.18 mmHg.  Mitral valve mean gradient 16.1± 5.36 
mmHg.  
 EF slope ranged 22.2 ± 2.27mm/sec. LVOT diameter was 1.8 ± 1 cm. Right 
ventricular diastolic diameter was 25 ± 2 mm. Aortic end systolic diameters 25± 3 
mm.    The pulmonary artery systolic pressure 59.8 ± 18.61mmHg. Mean 
Pulmonary artery pressure 39 ± 13.15mmHg. Left atrial mean pressure 24.2 ± 
4.96mmHgG. Right ventricle systolic pressure was 59.8 ± 18.6mmHg. Right atrial 
mean pressure 7.3 ± 1.4mmHg. One patient under went previous balloon mitral 
valvotomy. Twenty one patients were noted to have mild mitral regurgitation. The 
Wilkins score was 3± 2.  
 After the Balloon mitral valvotomy their functional capacity improved to 
NYHA class I.  Left atrial diameter decreased to 39.2 ± 2.4mm.  Mitral valve 
orifice increased to 1.45±0.19cm2.  MV PHT decreased to 150 ± 20ms.  Mitral 
valve peak gradient decreased to 11.8 ± 2.95 mmHg.  Mitral valve mean gradient 
reduced to 7.3 ± 2.14 mmHg. RV diastolic diameter was reduced in size 15 ± 
2mm.  The mean pulmonary artery pressure decreased to 23.2 ± 9.38mmHg.  The 
left arterial mean pressure considerably decreased to 10.5 ± 3.09 mmHg. The right 
ventricular systolic pressure decreased to 36.0 ± 11.3 mmHg. 
  The Real Time 3D Echocardiogram showed well delineated commissural 
splitting and atrial puncture site.  It also clearly visualized rupture of anterior 
mitral leaflet.  Out of Thirty five patients, ten patients had bilateral commissural 
splitting. Eighteen patients showed unilateral splitting of commissure.    RT3DE 
was able to identify asymmetrical splitting of commissures in seven patients who 
had mild to moderate mitral regurgitation. Three patients had rupture of anterior 
mitral leaflet in addition to asymmetrical splitting of commissure which 
transthoracic Echocardiogram had failed to visualize. One Patient had two atrial 
septal puncture sites which were clearly visualized by RT3DE.  
 Parameters Pre-BMV Post-BMV P-value 
NYHA Class II-III Class I <0.05 
Left atrium diameter (mm) 45.1±3.2 39.2±2.4 <0.05 
Mitral valve orifice (cm2) 0.7±0.17 1.45±0.19 <0.05 
Mitral valve peak gradient 
(mmHg) 
25.0±8.18 11.8±2.95 <0.05 
Mitral valve mean gradient 
(mmHg) 
16.1±5.36 7.3±2.14 <0.05 
Pulmonary artery systolic 
pressure (mmHg) 
59.8±18.61 36.0±11.13 <0.05 
Mean pulmonary artery 
pressure (mmHg) 
39.0±13.15 23.2±9.38 <0.05 
Left atrial mean pressure 
(mmHg) 
24.2±4.96 10.5±3.09 <0.05 
RA mean pressure (mmHg) 7.3±1.47 6.4±0.96 <0.05 
RV systolic pressure (mmHg) 59.8±18.61 36.0±11.13 <0.05 
MVO Continuity 
equation(cm2) 
0.65 ±0.17 1.5 ±0.18 <0.05 
MVO (cm2) RT3DE 0.7±0.17 1.46±0.17 <0.05 
 
Table 3: Echocardiographic and haemodynamic characters in  pre and post BMV 
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Bar diagram1: Left atrial size in pre and post BMV 
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Bar diagram2: Mitral valve orifice in cm2 size in pre and post BMV 
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  Bar diagram 3: Trans mitral valve peak gradient in pre and post BMV 
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Bar diagram 4: Trans mitral valve mean gradient in pre and post BMV 
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Bar diagram 5: Systolic pulmonary artery pressure in pre and post BMV 
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Bar diagram 6: Mean pulmonary artery pressure in pre and post BMV 
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Bar diagram 7:  pulmonary artery diastolic pressure in pre and post BMV 
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Bar chart 1: Left atrial mean pressure in pre and post BMV 
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Bar chart 2: Right ventricular systolic pressure in pre and post BMV 
                      
2DE & 3DE Pictures show bilateral commissural fusion – pre BMV 
                     
                       
                  
                  2DE & 3DE Pictures show unilateral commissural splitting –post BMV 
 
                    
 
                  
                  2DE & 3DE pictures show bilateral commissural fusion –pre BMV 
                      
 
 
                    
                   2DE picture shows unilateral splitting of medial commissure-post BMV 
                   3DE picture shows tear of AML in the same patient-post BMV 
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                    2DE & 3DE pictures show rupture of AML-post BMV  
                    
 
 
                 
                2DE & 3DE pictures show bilateral commissural fusion-pre BMV 
                   
    
 
 
 
 
   
 
 
 
         
     
 
 
 
 
 
 
             
 
 
 
 
 
 
 
 
            
 
 
2DE & 3DE pictures show bilateral commissural splitting –post BMV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
2DE & 3DE pictures show two atrial puncture sites-post BMV 
 
 
DISCUSSION 
Percutaneous BMV is a safe, effective, less invasive alternative to surgery for 
selected patients with mitral stenosis. It has been shown to convey a similar improvement 
in 
hemodynamics, valve area and symptoms for up to 2 years after the procedure as 
compared with open surgical commissurotomy24. 
 
 It is, however, not without morbidity, the most serious being cardiac perforation, 
systemic emboli and the development of mitral regurgitation25 . These potentially lethal 
complications can be minimized with the use of echocardiography. Doppler 
echocardiography has a clear and well-established role in evaluating patients with mitral 
stenosis who undergo BMV. 
 
 Transthoracic echocardiography is a standard screening tool that is used to assess 
the mitral valve and submitral apparatus in patients who are potential candidates for this 
procedure. It has also been used to monitor patients during BMV. Immediately before 
BMV, Tranthoracic echocardiography used to clearly visualize the left atrium, left atrial 
appendage and interatrial septum for the presence of thrombi, which are a potential 
source for systemic embolization during the procedure. 
 
 During valvuloplasty Tranthoracic echocardiography has been shown to be an 
invaluable aid in guiding the transseptal puncture by visualizing the “Tenting” of the 
interatrial septum by the Brockenbrough needle. 
 
 
 Tranthoracic echocardiography is also useful in guiding the balloon catheter 
across the mitral valve and obtaining a quick and accurate assessment of the mitral valve 
area and the amount of mitral regurgitation.  
 
After valvuloplasty Tranthoracic echocardiography can assess the adequacy of the 
procedure and identify the presence, exact location and size of iatrogenic atrial septal 
defects. 
 In this study we have shown the advantages of obtaining three-dimensional 
echocardiographic reconstructions during BMV. This technique offers the ability to view 
the mitral valve from any cut-plane of the three-dimensional data set. By viewing the 
mitral valve from the perspective of looking up from the left ventricle, the mitral leaflets, 
commissures and mitral annulus were easily visualized en-face. 
 
 The two dimensional Tranthoracic echocardiography can accurately visualize a 
larger mitral valve orifice or an increase in the amount of mitral regurgitation. However, 
it is often difficult and potentially inaccurate to mentally reconstruct a three-dimensional 
image from the two-dimensional echocardiographic images. Therefore, by comparing the 
initial three-dimensional reconstruction to the one obtained after the procedure, the extent 
of commissural 
splitting was easily evaluated and was shown to be related to the extent of improvement 
in mitral valve area with BMV.  
 
When the development of worsening of mitral insufficiency complicated BMV, 
leaflet tears were visualized in three patients. What three-dimensional reconstruction 
provides that is not obtainable from two-dimensional echocardiography is the mechanism 
by which valve area increases, as well as the detection of leaflet tear. 
 The three-dimensional echocardiographic reconstructions correlate well with what 
is seen on pathologic specimens and direct visual inspection of the valves of patients who 
underwent .MV. Hogan et al27.  analyzed pathologic specimens of mitral valves in 11 
patients who underwent BMV and found that fracture of the commissural fusion was the 
fundamental mechanism for the success of the procedure. This was also described by 
Inoue et al28. who were the first to describe the anatomic mechanism of successful BMV 
in patients undergoing open commissurotomy. Tears of the mitral valve leaflet were 
shown to be responsible for the development of mitral regurgitation secondary to balloon 
valvuloplasty in three-fifths of mitral valves studied pathologically. BMV has become the 
procedure of choice in symptomatic patients when the stenotic mitral valve is not heavily 
calcified and mitral regurgitation is not significant because it is cost effective and safe. 
This technique may also be used in patients with less favourable anatomic features, 
particularly in patients who are considered to be at high surgical risk29, such as pregnant 
women30, very elderly patients, patients with associated severe ischaemic heart disease or 
associated severe pulmonary, renal, or malignant diseases. The results of BMV are 
equivalent to those of surgical, open commissurotomy and both give better results than 
closed commissurotomy31. 
 
Patients with Rheumatic mitral valve stenosis who require an intervention can be 
easily identified using non-invasive techniques and the results can be predicted by a 
careful pre- BMV Doppler echocardiographic evaluation. Before the BMV, the pressure 
gradient, the valvular area, and the severity of valvular regurgitation, can be used to 
evaluate patients reliably. Prior to BMV, Doppler echocardiographic estimation of MVA 
correlates well with invasive estimation. 
Immediately following BMV, the PHT method has been shown to have a poor 
agreement with invasive data32. There are various reasons for this inaccuracy including: 
(1) the development of an atrial septal defect in many patients after BMV33, and (2) the 
PHT method assumes that the left atrial and left ventricular compliances remain stable34; 
this assumption is not valid in the immediate period following BMV because rapid 
changes in the left atrial pressure and left ventricular filling occur in this setting, affecting 
the compliance of 
both the left atrium and ventricle.  
 
Compared to the PHT method, planimetry (2D or 3D) is not as dependent on 
haemodynamic variables (heart rate, cardiac index, cardiac rhythm, left ventricular 
systolic and diastolic dysfunction, left ventricular and atrium compliance, left ventricular 
hypertrophy and concomitant valvular disease) 35. Accordingly, planimetry of MVA 
should be more accurate in the setting of PMV. 
 
Planimetry of mitral valve orifice using 2D echo is a valid method but has its own 
set of limitations, especially following valvuloplasty when the mitral orifice becomes 
irregular and technically difficult to trace, particularly if calcium is present.  
 
3D echo allows a different and superior evaluation of the mitral valve apparatus, 
improving the ability to obtain an accurate measurement of the MVA36. Restriction of the 
tips and chordae, during the evolution of the rheumatic mitral valve disease, effectively 
converts the mitral valve apparatus into a funnel with its restrictive mitral valve orifice 
being at the tips of the leaflets. Due to the variable geometry of the stenotic mitral valve 
orifice, correct plane orientation frequently becomes difficult. 
 
 Minor changes in depth and angle of the ultrasound beam leads to an 
overestimation of the MVA by anywhere from 63% to 88%37. 3D echo has already been 
shown to be useful to optimise the results and prevent the development of significant 
mitral regurgitation during balloon mitral valvuloplasty38. The use of the new 
transthoracic 3D matrix array probe that allows on-line 3D rendering, allows fast 
visualization of the mitral valve apparatus and the acquisition of en face views of the 
mitral valve from which the accurate measurements of the mitral valve area can be made. 
This image modality should be routinely used to both monitor the mitral BMV and obtain 
accurate MVA measurements. 
 
In this study, RT3D was the most accurate echocardiographic technique for 
measuring MVA. Compared with PHT and 2D echo planimetry, RT3D echo had the best 
agreement when compared to the invasively derived MVA. Not only did this occur in the 
pre-BMV period but also in the post-BMV period. 
Thus, our results show that RT3D is an accurate and practical non-invasive tool 
for measuring MVA in all clinical situations, including the immediate post-BMV period. 
Importantly, since manipulation of the RT3D echo probe is similar to other clinically 
used transthoracic 2D probes, sonographers do not need a long training period to be 
versatile with RT3D image acquisition39. 
We need to know, that although 3D echo provides a more accurate evaluation of 
the anatomy of the mitral valve, as with 2D echo, it is importantly influenced by the 
quality of the acoustic window. Needless to say that although the new equipment 
provides better resolution and image quality, a bad acoustic window will lead to a poor 
analysis of the patient. 
 
LIMITATIONS 
There are several possible limitations of three-dimensional volume-rendered 
echocardiographic reconstructions. This technique is extremely sensitive to proper gain 
settings from the two-dimensional data acquisition as well as to the level of threshold 
chosen (which defines the interface between tissue and blood) during the three-
dimensional reconstruction. An inappropriate setting of either modality can result in 
ultrasonographic dropout, which would distort the accurate visualization of the valve 
anatomy. 
  
During  data acquisition three-dimensional echocardiographic reconstructions are 
also very sensitive to both patient and operator movement, either of which can distort the 
image. Also, the time required for data acquisition and reconstruction, although 
improving, is still too long for the three-dimensional data to be obtained between balloon 
inflations. 
 
  Measuring the mitral valve area by pressure half-time after BMV can be 
inaccurate secondary to changes in left atrial and ventricular compliance as well as the 
creation of an atrial septal defect40. The three-dimensional reconstruction allows us to 
measure the mitral valve area by planimetry by choosing the cut-plane with the smallest 
mitral valve orifice. Although three-dimensional planimetry could be affected by gain 
settings and post processing, we found these results to be similar to the mitral valve area 
measured by pressure half-time, and we believe that this merits further investigation with 
a larger number of patients. 
 
 CONCLUSIONS 
1. Three-dimensional echocardiographic reconstruction of the mitral valve obtained 
by transthoracic echocardiography during BMV is a new, noninvasive imaging 
technique that can more accurately visualize the mechanisms of successful BMV, 
as well as some of its complications.  
2. This can potentially be used to further guide and optimize the results of BMV by 
visualizing the extent of commissural splitting so that a maximal mitral valve area 
can be obtained safely. It may also help to prevent the development of significant 
mitral regurgitation during the procedure. Visualizing a small tear of the mitral 
valve leaflet associated with only minimal valvular regurgitation may prevent 
another balloon inflation that may worsen the tear and create more significant 
mitral regurgitation. 
3. Further improvements in the hardware and software of this echocardiographic 
system are needed to test this hypothesis so that larger studies transthoracic 
RT3DE is a feasible and accurate technique for measuring MVA in patients with 
Rheumatic mitral valve stenosis compared to the PHT method and 2D echo 
planimetry, RT3DE results have the best agreement with the invasively 
determined MVA, particularly in the immediate post-BMV period, where PHT is 
inaccurate. 
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GLOSSARY AND ACRONYMS 
BMV-Balloon mitral valvotomy 
PTMC-Percutaneous transvenous mitral valve commissurotomy 
RT3DE-Real time three dimensional echocardiogram 
PMC - Percutaneous mitral valve commissurotomy 
TTE-Tran thoracic echocardiogram 
TEE-Trans esophageal echocardiogram 
LA-Left atrium 
PHT –Pressure half time 
MVA-Mitral valve area 
 
 
 
 
 
 
 
